- Home
- CETY vs SABS Comparison
CETY vs SABS Comparison
Compare CETY & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CETY
- SABS
- Stock Information
- Founded
- CETY 1993
- SABS 2014
- Country
- CETY United States
- SABS United States
- Employees
- CETY N/A
- SABS N/A
- Industry
- CETY Power Generation
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- CETY Utilities
- SABS Health Care
- Exchange
- CETY Nasdaq
- SABS Nasdaq
- Market Cap
- CETY 22.4M
- SABS 19.0M
- IPO Year
- CETY N/A
- SABS N/A
- Fundamental
- Price
- CETY $0.39
- SABS $1.10
- Analyst Decision
- CETY
- SABS Strong Buy
- Analyst Count
- CETY 0
- SABS 5
- Target Price
- CETY N/A
- SABS $11.40
- AVG Volume (30 Days)
- CETY 100.0K
- SABS 39.7K
- Earning Date
- CETY 05-19-2025
- SABS 05-19-2025
- Dividend Yield
- CETY N/A
- SABS N/A
- EPS Growth
- CETY N/A
- SABS N/A
- EPS
- CETY N/A
- SABS N/A
- Revenue
- CETY $11,779,593.00
- SABS $1,322,410.00
- Revenue This Year
- CETY N/A
- SABS N/A
- Revenue Next Year
- CETY N/A
- SABS $25.00
- P/E Ratio
- CETY N/A
- SABS N/A
- Revenue Growth
- CETY 119.20
- SABS N/A
- 52 Week Low
- CETY $0.39
- SABS $1.00
- 52 Week High
- CETY $1.79
- SABS $5.01
- Technical
- Relative Strength Index (RSI)
- CETY 38.07
- SABS 27.84
- Support Level
- CETY $0.48
- SABS $1.11
- Resistance Level
- CETY $0.51
- SABS $1.80
- Average True Range (ATR)
- CETY 0.05
- SABS 0.15
- MACD
- CETY -0.02
- SABS -0.02
- Stochastic Oscillator
- CETY 11.64
- SABS 16.25
About CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business, as well as continuing to support other emerging growth companies with their Clean-tech technologies. It has four segments: Clean Energy HRS & CETY Europe, CETY HK, CETY Renewables and Electronic Manufacturing. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.